Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

Nadia BouabdallaouiEileen O'MearaVirginie BernierMichel KomajdaKarl SwedbergLuigi TavazziJeffrey S BorerMichael BohmIan FordJean-Claude Tardif

Published in: ESC heart failure (2019)

In patients with chronic HFrEF, sinus rhythm, and a heart rate > 77 b.p.m. while on GDMT, the present analysis brings novel insights into the role of ivabradine in improving the management of HFrEF, particularly with regard to PRO (ISRCTN70429960).

Keyphrases

heart rate
ejection fraction
heart rate variability
blood pressure
aortic stenosis
heart failure
transcatheter aortic valve replacement
aortic valve
coronary artery disease